Abstract
We report a case of paraneoplastic liver dysfunction associated with a renal cell carcinoma, which disappeared after surgery. A 62-year-old male presented with fatigue and weight loss. The most prominent laboratory abnormality was elevated alkaline phosphatase, C-reactive protein, and interleukin-6 while normal aminotransferases. Computed tomography scan revealed a solid mass in the left kidney. A left radical nephrectomy was performed. After the surgery, biochemical abnormalities returned to normal.
Similar content being viewed by others
References
Wein AJ, Kavoussi LR, Novick AC et al (2011) Campbell-Walsh Urology, 10th edn. Elsevier Health Sciences, Philadelphia
Giannakos G, Papanicolaou X, Trafalis D et al (2005) Stauffer’s syndrome variant associated with renal cell carcinoma. Int J Urol 12(8):757–759
Blay JY, Rossi JF, Wijdenes J et al (1997) Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 72:424–430
Gold PJ, Fefer A, Thompson JA (1996) Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol 14:216–222
Miki S, Iwano M, Miki Y et al (1989) Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250:607–610
Chuang YC, Lin AT, Chen KK et al (1997) Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis. J Urol 158:1684–1687
Mortensen RF (2001) C-reactive protein, inflammation, and innate immunity. Immunol Res 24:163–176
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human subjects
All procedures performed in this report involving human participants were in accordance with the ethical standards of the institutional ethical committee.
About this article
Cite this article
Takamatsu, K., Mizuno, R., Hattori, S. et al. A case of paraneoplastic liver dysfunction with elevated serum interleukin-6 in clinically localized renal cell carcinoma. Int Canc Conf J 5, 66–67 (2016). https://doi.org/10.1007/s13691-015-0229-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-015-0229-3